129 related articles for article (PubMed ID: 25652269)
1. Formulation and characterization of atropine sulfate in albumin-chitosan microparticles for in vivo ocular drug delivery.
Addo RT; Yeboah KG; Siwale RC; Siddig A; Jones A; Ubale RV; Akande J; Nettey H; Patel NJ; Addo E; D'Souza MJ
J Pharm Sci; 2015 May; 104(5):1677-90. PubMed ID: 25652269
[TBL] [Abstract][Full Text] [Related]
2. Formulation, characterization and testing of tetracaine hydrochloride-loaded albumin-chitosan microparticles for ocular drug delivery.
Addo RT; Siddig A; Siwale R; Patel NJ; Akande J; Uddin AN; D'Souza MJ
J Microencapsul; 2010; 27(2):95-104. PubMed ID: 20055748
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle formation by using shellac and chitosan for a protein delivery system.
Kraisit P; Limmatvapirat S; Nunthanid J; Sriamornsak P; Luangtana-anan M
Pharm Dev Technol; 2013; 18(3):686-93. PubMed ID: 22568768
[TBL] [Abstract][Full Text] [Related]
4. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye.
Nagarwal RC; Kumar R; Pandit JK
Eur J Pharm Sci; 2012 Nov; 47(4):678-85. PubMed ID: 22922098
[TBL] [Abstract][Full Text] [Related]
5. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
Huang YC; Chiang CH; Yeh MK
J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
[TBL] [Abstract][Full Text] [Related]
6. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
Alhalaweh A; Andersson S; Velaga SP
Eur J Pharm Sci; 2009 Oct; 38(3):206-14. PubMed ID: 19616094
[TBL] [Abstract][Full Text] [Related]
7. Preparation of chitosan microspheres by ionotropic gelation under a high voltage electrostatic field for protein delivery.
Ma L; Liu C
Colloids Surf B Biointerfaces; 2010 Feb; 75(2):448-53. PubMed ID: 19819676
[TBL] [Abstract][Full Text] [Related]
8. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.
Enríquez de Salamanca A; Diebold Y; Calonge M; García-Vazquez C; Callejo S; Vila A; Alonso MJ
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1416-25. PubMed ID: 16565375
[TBL] [Abstract][Full Text] [Related]
9. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
[TBL] [Abstract][Full Text] [Related]
10. Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods.
Cerchiara T; Abruzzo A; di Cagno M; Bigucci F; Bauer-Brandl A; Parolin C; Vitali B; Gallucci MC; Luppi B
Eur J Pharm Biopharm; 2015 May; 92():112-9. PubMed ID: 25769679
[TBL] [Abstract][Full Text] [Related]
11. Protein delivery based on uncoated and chitosan-coated mesoporous silicon microparticles.
Pastor E; Matveeva E; Valle-Gallego A; Goycoolea FM; Garcia-Fuentes M
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):601-9. PubMed ID: 21855304
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight chitosan-coated liposomes for ocular drug delivery: in vitro and in vivo studies.
Li N; Zhuang CY; Wang M; Sui CG; Pan WS
Drug Deliv; 2012 Jan; 19(1):28-35. PubMed ID: 22070752
[TBL] [Abstract][Full Text] [Related]
13. Preparation and Characterization of an Oral Vaccine Formulation Using Electrosprayed Chitosan Microparticles.
Moreno JAS; Panou DA; Stephansen K; Chronakis IS; Boisen A; Mendes AC; Nielsen LH
AAPS PharmSciTech; 2018 Nov; 19(8):3770-3777. PubMed ID: 30280354
[TBL] [Abstract][Full Text] [Related]
14. Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific delivery.
Mura C; Nácher A; Merino V; Merino-Sanjuán M; Manconi M; Loy G; Fadda AM; Díez-Sales O
Colloids Surf B Biointerfaces; 2012 Jun; 94():199-205. PubMed ID: 22341520
[TBL] [Abstract][Full Text] [Related]
15. Chitosan microparticles for sustaining the topical delivery of minoxidil sulphate.
Gelfuso GM; Gratieri T; Simão PS; de Freitas LA; Lopez RF
J Microencapsul; 2011; 28(7):650-8. PubMed ID: 21824068
[TBL] [Abstract][Full Text] [Related]
16. Impact of surfactant selection on the formulation and characterization of microparticles for pulmonary drug delivery.
Cocks E; Alpar O; Somavarapu S; Greenleaf D
Drug Dev Ind Pharm; 2015 Mar; 41(3):522-8. PubMed ID: 24650006
[TBL] [Abstract][Full Text] [Related]
17. Properties of a Stable and Sustained-Release Formulation of Recombinant Human Parathyroid Hormone (rhPTH) with Chitosan and Silk Fibroin Microparticles.
Lv BH; Tan W; Zhu CC; Shang X; Zhang L
Med Sci Monit; 2018 Oct; 24():7532-7540. PubMed ID: 30345994
[TBL] [Abstract][Full Text] [Related]
18. Fabrication of microparticle protein delivery systems based on calcium alginate.
Yu CY; Jia LH; Cheng SX; Zhang XZ; Zhuo RX
J Microencapsul; 2010; 27(2):171-7. PubMed ID: 19538029
[TBL] [Abstract][Full Text] [Related]
19. Novel microparticle drug delivery systems based on chitosan and Eudragit® RSPM to enhance diltiazem hydrochloride release property.
Cetin EO; Gundogdu E; Kirilmaz L
Pharm Dev Technol; 2012; 17(6):741-6. PubMed ID: 21563988
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of a model protein into chitosan-bile salt microparticles.
Lameiro MH; Lopes A; Martins LO; Alves PM; Melo E
Int J Pharm; 2006 Apr; 312(1-2):119-30. PubMed ID: 16480840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
